Gastrohepatic Disorders

CymaBay’s PBC therapy shows promising results in phase 3

by Jovana Nikolic, MD

The latest findings from a post-hoc analysis of the phase 3 ENHANCE study were published in the journal Hepatology,
Study: Intense itching significantly lowers quality of life in PBC

by Jovana Nikolic, MD

A recent study shows intense itching, also known as pruritus, significantly reduces the life quality of patients with primary biliary cholangitis (PBC).
Study: Deep learning could aid treatment of elderly adults with PBC

by Jovana Nikolic, MD

A study shows deep learning can be used to guide treatment, predict ALBI scores, dose UDCA and prevent use of multiple drugs in elderly adults with PBC.
Several potential treatments for PBC in focus at international liver conference

by Ozge Ozkaya, MSc, PhD

There are a number of experimental treatments in late-stage clinical trials to potentially become new treatments for primary biliary cholangitis (PBC).
Study shows high and variable prevalence of PBC in the US

by Jovana Nikolic, MD

The prevalence of primary biliary cholangitis (PBC) in the U.S. may be high and variable between regions, according to a recent study.
High blood fat in PBC may not affect blood vessels and liver health

by Jovana Nikolic, MD

High blood levels of fats such as triglycerides and cholesterol in patients with PBC may not increase their risk for cardiovascular disease.